Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45results about How to "Size can be altered" patented technology

Method and system for providing load-sensitive bandwidth allocation

An approach is provided for managing bandwidth in a data network. Capacity is allocated on a communication channel, which can be utilized for transporting data traffic or support network administrative functions (e.g., ranging), for a terminal to transmit data over the communication channel. In anticipation of the terminal having to transmit additional data, additional capacity is allocated on the communication channel for the terminal prior to receiving a request for bandwidth by the terminal. The anticipatory allocation is determined according to loading of the data network. This approach as particular applicability to shared capacity systems, such as a satellite communication system.
Owner:HUGHES NETWORK SYST

Apparatus for providing facial support

An apparatus for providing facial support includes a head band, a head strap, a cheek support, a forehead strap and a nose band. The head band wraps around the top of the head and the chin. The cheek support is attached to the head band and provides support for the cheeks. The nose strap and the forehead band hold the apparatus in place on the user's face. The head strap is used to hold the apparatus on the face and to pull the cheek support into engagement with the cheeks. By applying support to the cheeks, sagging of the cheeks can be reduced or prevented.
Owner:TWENTIETH CENTURY FOX FILM CORP

Plastic package

A package including a front panel and a rear panel, preferably connected by a hinge, for example by a living hinge, whereby the front and rear panels include substantially A-frame elements adapted to be separated to expose an interior volume defined by such panels. The interior volume may be sized and shaped to receive any of a number of products, such as a pet door. The package includes peripheral flanges that extend about the peripheral edge of each of the front panel and the rear panel such that when in the closed configuration, the package remains in a stable upright position when placed on a substantially horizontal surface. The size of the peripheral flanges may be altered, such as shortened, such that a bottom portion of the package rests substantially on (or substantially close to) a horizontal surface to provide further support when the contents of the package are heavy.
Owner:PACKAGE DEV

Cyclin-dependent kinase inhibitors and uses thereof

InactiveUS20080307546A1Increase influenceIncreased potential to storeBiocideFungiPTK InhibitorsPlant cell
Provided are DNA sequences encoding cyclin-dependent kinase inhibitor(s) as well as to methods for obtaining the same. Furthermore, vectors comprising said DNA sequences are described, wherein the DNA sequences are operatively linked to regulatory elements allowing expression in prokaryotic and/or eukaryotic host cells. In addition, proteins encoded by said DNA sequences, antibodies to said proteins and methods for their production are provided. Furthermore, regulatory sequences which naturally regulate the expression of the above described DNA sequences are described. Also described is a method for controlling or altering growth characteristics of a plant and/or a plant cell comprising introduction and/or expression of one or more cyclin-dependent kinase inhibitor(s) functional in a plant or parts thereof and/or one or more DNA sequences encoding such proteins. Also provided is a process for disruption plant cell division by interfering in the expression or activity of a cyclin-dependent protein kinase inhibitor using a DNA sequence according to the invention wherein said plant cell is part of a transgenic plant. Further described are diagnostic compositions comprising the aforementioned DNA sequences, proteins, antibodies and regulatory sequences. Methods for the identification of compounds being capable of activating or inhibiting the cyclin-dependent kinase inhibitors are described as well. Furthermore, transgenic plant cells, plant tissue and plants containing the above-described DNA sequences and vectors are described as well as the use of the aforementioned DNA sequences, vectors, proteins, antibodies, regulatory sequences and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding and/or agriculture.
Owner:VEYLDER LIEVEN DE +4
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products